Interpace Biosciences Inc (IDXG)
3.09
-0.19
(-5.79%)
USD |
OTCM |
Nov 14, 15:46
Interpace Biosciences Total Liabilities (Quarterly): 72.00M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 72.00M |
| March 31, 2024 | 73.28M |
| December 31, 2023 | 74.69M |
| September 30, 2023 | 76.93M |
| June 30, 2023 | 78.15M |
| March 31, 2023 | 78.42M |
| December 31, 2022 | 79.05M |
| September 30, 2022 | 76.89M |
| June 30, 2022 | 83.44M |
| March 31, 2022 | 82.70M |
| December 31, 2021 | 80.84M |
| September 30, 2021 | 78.96M |
| June 30, 2021 | 78.98M |
| March 31, 2021 | 76.75M |
| December 31, 2020 | 74.76M |
| September 30, 2020 | 72.50M |
| June 30, 2020 | 76.74M |
| March 31, 2020 | 71.67M |
| December 31, 2019 | 29.85M |
| September 30, 2019 | 51.08M |
| June 30, 2019 | 19.50M |
| March 31, 2019 | 18.61M |
| December 31, 2018 | 15.68M |
| September 30, 2018 | 13.77M |
| June 30, 2018 | 12.80M |
| Date | Value |
|---|---|
| March 31, 2018 | 13.33M |
| December 31, 2017 | 13.73M |
| September 30, 2017 | 14.01M |
| June 30, 2017 | 17.40M |
| March 31, 2017 | 22.41M |
| December 31, 2016 | 35.25M |
| September 30, 2016 | 47.44M |
| June 30, 2016 | 47.52M |
| March 31, 2016 | 48.47M |
| December 31, 2015 | 54.67M |
| September 30, 2015 | 93.43M |
| June 30, 2015 | 97.28M |
| March 31, 2015 | 95.99M |
| December 31, 2014 | 95.78M |
| September 30, 2014 | 36.80M |
| June 30, 2014 | 30.11M |
| March 31, 2014 | 34.04M |
| December 31, 2013 | 36.58M |
| September 30, 2013 | 37.21M |
| June 30, 2013 | 39.56M |
| March 31, 2013 | 44.92M |
| December 31, 2012 | 42.82M |
| September 30, 2012 | 46.89M |
| June 30, 2012 | 45.08M |
| March 31, 2012 | 49.36M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
29.85M
Minimum
Dec 2019
83.44M
Maximum
Jun 2022
74.56M
Average
76.89M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Fonar Corp | 57.46M |
| XWELL Inc | 19.06M |
| ProPhase Labs Inc | 49.60M |
| Applied DNA Sciences Inc | 4.456M |
| Veracyte Inc | 98.98M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.97M |
| Shareholders Equity (Quarterly) | -59.03M |
| Debt to Equity Ratio | -0.1149 |
| Current Ratio | 0.5342 |
| Net Debt Paydown Yield | 26.02% |